ArticleFrontiers in cardiovascular medicine2023

Evaluation of early left-sided cardiac reverse remodeling under combined therapy of sacubitril-valsartan and spironolactone compared with angiotensin-converting enzyme inhibitors and spironolactone.

Wioletta Sacharczuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.